These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 35864972)
1. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis. Sun ZP; Tan ZG; Peng C; Yi WM J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226 [TBL] [Abstract][Full Text] [Related]
3. m Zheng H; Zhu M; Li W; Zhou Z; Wan X Liver Int; 2022 May; 42(5):1144-1157. PubMed ID: 35274813 [TBL] [Abstract][Full Text] [Related]
4. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis. Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421 [TBL] [Abstract][Full Text] [Related]
5. PCAT1 induced by transcription factor YY1 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-216a-3p to up-regulate oncogene BCL3. Sun D; Zhao Y; Wang W; Guan C; Hu Z; Liu L; Jiang X Biol Chem; 2021 Jan; 402(2):207-219. PubMed ID: 33544468 [TBL] [Abstract][Full Text] [Related]
6. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L; Jiang G; Lu J; Wang L Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis. Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545 [TBL] [Abstract][Full Text] [Related]
8. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691 [TBL] [Abstract][Full Text] [Related]
9. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1. Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H Biochem J; 2020 Sep; 477(18):3527-3540. PubMed ID: 32812642 [TBL] [Abstract][Full Text] [Related]
10. PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1. Sun D; Li F; Liu L; Yu S; Wang H; Gao X; Liu G; Zhao Y; Qiu G; Jiang X Aging (Albany NY); 2022 Jan; 14(1):509-525. PubMed ID: 35022330 [TBL] [Abstract][Full Text] [Related]
11. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation. Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150 [TBL] [Abstract][Full Text] [Related]
12. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN. Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725 [TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p. Li J; Guan C; Hu Z; Liu L; Su Z; Kang P; Jiang X; Cui Y Hum Cell; 2021 Jan; 34(1):187-200. PubMed ID: 33040228 [TBL] [Abstract][Full Text] [Related]
14. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332 [TBL] [Abstract][Full Text] [Related]
15. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8. Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895 [TBL] [Abstract][Full Text] [Related]
16. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma. Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991 [TBL] [Abstract][Full Text] [Related]
17. JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis. Lei S; Cao W; Zeng Z; Zhang Z; Jin B; Tian Q; Wu Y; Zhang T; Li D; Hu C; Lan J; Zhang J; Chen T Cell Death Dis; 2022 Nov; 13(11):967. PubMed ID: 36400758 [TBL] [Abstract][Full Text] [Related]
18. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis. Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690 [TBL] [Abstract][Full Text] [Related]
19. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Chen T; Wang H; Yan H Cell Cycle; 2022 Oct; 21(19):2079-2090. PubMed ID: 35670491 [TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis. Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]